Alhambra Expósito María Rosa, Herrera-Martínez Aura D, Manzano García Gregorio, Espinosa Calvo María, Bueno Serrano Carmen María, Gálvez Moreno María Ángeles
.
Nutr Hosp. 2018 Jun 5;35(3):505-510. doi: 10.20960/nh.1560.
weight loss is commonly observed in head-neck cancer patients, affecting 75-80% of them during their treatment period; weight loss is severe in 30-50% of cases. According to ESPEN publications, nutritional assessment in cancer patients should be frequently performed and nutrition support therapy must be started when any deficiency is observed.
to evaluate the effect of early nutrition support (ENS) in nutritional markers and treatment response in patients with head-neck cancer receiving radiotherapy (RT).
one hundred and two patients with head-neck cancer and more than two points in the malnutrition screening tool (MUST) before receiving RT were included. ENS was provided to all patients consisting in nutrition counselling, oral supplements and/or enteral nutrition.
one hundred and two patients were included; 76% had a stage IV of disease. At the end of RT, after ENS, a slightly decreased body mass index (BMI) with an increased fat-free body mass was observed (p < 0.001); biochemical nutrition parameters remained stable despite decreased oral intake. Less than 40% of patients had severe epithelitis or mucositis; 92% of patients received the total amount and doses of originally planned RT sessions, while 22.8% required RT-sessions interruption. Patients with caloric malnutrition had a lower fulfillment of RT than those without caloric malnutrition (p < 0.001). Mortality was related to lower Karnosfsky, higher weight loss before RT and higher grade of mucositis/epitelitis (p < 0.05).
patients who receive ENS keep their nutritional condition instead of associated effects due to RT. ENS represents an efficient treatment and could prevent malnutrition associated comorbidities in oncologic patients.
头颈癌患者中体重减轻现象普遍存在,75%至80%的患者在治疗期间会出现体重减轻;30%至50%的病例体重减轻严重。根据欧洲临床营养和代谢学会(ESPEN)的出版物,癌症患者应经常进行营养评估,一旦发现任何营养缺乏,就必须开始营养支持治疗。
评估早期营养支持(ENS)对接受放疗(RT)的头颈癌患者营养指标及治疗反应的影响。
纳入102例在接受放疗前营养不良筛查工具(MUST)评分超过2分的头颈癌患者。所有患者均接受包括营养咨询、口服补充剂和/或肠内营养的ENS。
纳入102例患者;76%为IV期疾病。放疗结束时,接受ENS后,观察到体重指数(BMI)略有下降,无脂肪体重增加(p<0.001);尽管口服摄入量减少,但生化营养参数保持稳定。不到40%的患者出现严重的食管炎或口腔炎;92%的患者接受了原计划放疗疗程的总量和剂量,而22.8%的患者需要中断放疗疗程。存在热量营养不良的患者放疗完成率低于无热量营养不良的患者(p<0.001)。死亡率与较低的卡诺夫斯基评分、放疗前较高的体重减轻以及较高等级的口腔炎/食管炎相关(p<0.05)。
接受ENS的患者保持了营养状况,而非因放疗产生相关影响。ENS是一种有效的治疗方法,可预防肿瘤患者营养不良相关的合并症。